Loading video...

Video Failed to Load

Go Home

A Cancer Study With 84% Positive Results. The NIH Should Have Done This. Nearly 200 patients. Prostate. Breast. Lung. Solid organ cancers — many already metastatic. 48% reported regression. 36% held stable. The combination is widely available, inexpensive, and now under peer review. The National Cancer Institute still hasn't...

McCulloughFund's profile picture

McCullough Foundation

77,442 subscribers

40,752 views • 4 months ago •via X (Twitter)

LIVE

Anya Rossi• Live Now

Private livecam show

0 Comments

No comments available

Comments from the original post will appear here

Related Videos

Cancer Breakthrough: Two Cheap Generic Drugs. One Stunning Combination. Ivermectin and mebendazole — both FDA-approved, both widely available, both dirt cheap — are showing results in solid organ cancers that expensive chemotherapy protocols can't match on safety alone. Large-scale randomized trials are the next step. The data is already there to justify them. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Live From Studio 6B Live From Studio 6B #MedicalFreedom
1:36

Cancer Breakthrough: Two Cheap Generic Drugs. One Stunning Combination. Ivermectin and mebendazole — both FDA-approved, both widely available, both dirt cheap — are showing results in solid organ cancers that expensive chemotherapy protocols can't match on safety alone. Large-scale randomized trials are the next step. The data is already there to justify them. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Live From Studio 6B Live From Studio 6B #MedicalFreedom

McCullough Foundation

22,830 views • 4 months ago

Ivermectin + Mebendazole Is Outperforming Cancer Treatments Nobody Can Afford. 48% reported actual tumor regression. 36% held stable. Only 15% worsened — in a population of nearly 200 solid organ cancer patients, many already widely metastatic. These are preliminary patient-reported outcomes. They are also the most encouraging cancer data most people haven't heard about. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Just The News No Noise, John Solomon John Solomon #MedicalFreedom
1:27

Ivermectin + Mebendazole Is Outperforming Cancer Treatments Nobody Can Afford. 48% reported actual tumor regression. 36% held stable. Only 15% worsened — in a population of nearly 200 solid organ cancer patients, many already widely metastatic. These are preliminary patient-reported outcomes. They are also the most encouraging cancer data most people haven't heard about. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Just The News No Noise, John Solomon John Solomon #MedicalFreedom

McCullough Foundation

24,031 views • 4 months ago

Ivermectin + Mebendazole: The Cancer Study That Changes the Conversation. Two anti-infective drugs. Both already FDA-approved. Both already widely available. Together they reduce cancer cell proliferation, cut off the tumor's blood supply, and trigger cancer cell self-termination. 84% net clinical benefit across prostate, breast, and lung cancer patients. The National Cancer Institute needs to move on this now. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), American Sunrise #MedicalFreedom
1:50

Ivermectin + Mebendazole: The Cancer Study That Changes the Conversation. Two anti-infective drugs. Both already FDA-approved. Both already widely available. Together they reduce cancer cell proliferation, cut off the tumor's blood supply, and trigger cancer cell self-termination. 84% net clinical benefit across prostate, breast, and lung cancer patients. The National Cancer Institute needs to move on this now. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), American Sunrise #MedicalFreedom

McCullough Foundation

15,826 views • 4 months ago

Social Media Knew About Ivermectin and Cancer Before the Institutions Did. That Should Embarrass Them. Patients were already talking about it. Requesting it. Using it. A private company tracked the outcomes because no major research body would. Now Johns Hopkins and Cedars-UCLA are finally running protocols. The conversation started in the places they told you not to trust. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Live From Studio 6B Live From Studio 6B #MedicalFreedom
1:11

Social Media Knew About Ivermectin and Cancer Before the Institutions Did. That Should Embarrass Them. Patients were already talking about it. Requesting it. Using it. A private company tracked the outcomes because no major research body would. Now Johns Hopkins and Cedars-UCLA are finally running protocols. The conversation started in the places they told you not to trust. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Live From Studio 6B Live From Studio 6B #MedicalFreedom

McCullough Foundation

29,220 views • 4 months ago

Even the Minority Witness at Ron Johnson's Cancer Senate Hearings Had to Agree: COVID Vaccines Appear to Be Causing Cancer in Some People. Breast. Female reproductive. Colon cancer in women. Prostate. Lung. Colorectal in men. Cancer has been rising for two decades — but the curves have now taken a hockey stick upward inflection. The Senate hearing brought UK and US cancer experts together, and the conclusion was not disputed across party lines. Screen now. Re-screen. Total body MRI technology exists. We need to be ahead of this — because too many people are already at risk. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Live From Studio 6B Live From Studio 6B #MedicalFreedom
0:53

Even the Minority Witness at Ron Johnson's Cancer Senate Hearings Had to Agree: COVID Vaccines Appear to Be Causing Cancer in Some People. Breast. Female reproductive. Colon cancer in women. Prostate. Lung. Colorectal in men. Cancer has been rising for two decades — but the curves have now taken a hockey stick upward inflection. The Senate hearing brought UK and US cancer experts together, and the conclusion was not disputed across party lines. Screen now. Re-screen. Total body MRI technology exists. We need to be ahead of this — because too many people are already at risk. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Live From Studio 6B Live From Studio 6B #MedicalFreedom

McCullough Foundation

15,144 views • 1 month ago

197 Cancer Patients. 84% Reported Clinical Benefit. The Results Are In — And They're Encouraging. Prostate. Breast. Lung. Solid organ cancers across the board — nearly 200 patients tracked for six months on off-label ivermectin and mebendazole. About half saw cancer disappear or regress. A third held stable. The study is conditionally accepted in a peer-reviewed journal. Large-scale randomized trials are the next step. The data says start them now. Join the Fight: Courtesy of The Amber May Show Catch the full episode: #MedicalFreedom
1:17

197 Cancer Patients. 84% Reported Clinical Benefit. The Results Are In — And They're Encouraging. Prostate. Breast. Lung. Solid organ cancers across the board — nearly 200 patients tracked for six months on off-label ivermectin and mebendazole. About half saw cancer disappear or regress. A third held stable. The study is conditionally accepted in a peer-reviewed journal. Large-scale randomized trials are the next step. The data says start them now. Join the Fight: Courtesy of The Amber May Show Catch the full episode: #MedicalFreedom

McCullough Foundation

18,076 views • 3 months ago

The COVID Infection Alone — Without the Vaccine — May Have Already Increased Cancer Risk. The Vaccine Made It Worse. And Cancer Research Is Still Ignoring Both. The spike protein from the Wuhan lab-origin virus suppresses P53 and BRCA tumor surveillance systems. Infection loads it into the body. The vaccine loads in more. Research stratifying cancer outcomes by vaccination status, number of doses, product type, and number of COVID infections does not yet exist at scale. Companies aren't doing it. The NCI isn't funding it. Senator Ron Johnson's hearings are forcing the conversation. The data is being ignored — and that choice has a body count. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Live From Studio 6B Live From Studio 6B #MedicalFreedom
0:44

The COVID Infection Alone — Without the Vaccine — May Have Already Increased Cancer Risk. The Vaccine Made It Worse. And Cancer Research Is Still Ignoring Both. The spike protein from the Wuhan lab-origin virus suppresses P53 and BRCA tumor surveillance systems. Infection loads it into the body. The vaccine loads in more. Research stratifying cancer outcomes by vaccination status, number of doses, product type, and number of COVID infections does not yet exist at scale. Companies aren't doing it. The NCI isn't funding it. Senator Ron Johnson's hearings are forcing the conversation. The data is being ignored — and that choice has a body count. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Live From Studio 6B Live From Studio 6B #MedicalFreedom

McCullough Foundation

12,453 views • 1 month ago

JAMA Reported That Ivermectin and Mebendazole Use in Cancer Patients Has Skyrocketed. The NCI Has Been Watching. Now They Need to Act. A report from Rockwell and colleagues in JAMA confirms what patient data has been showing for over a year — use of ivermectin and mebendazole among cancer patients surged through 2025. Mel Gibson's appearance on Joe Rogan accelerated it further. The first clinical report shows 84% positive impact — cancers held stable or improved when the combination was added to traditional care. The National Cancer Institute is tracking this. The next step is a large prospective randomized double-blind placebo-controlled trial. The data is there. The patients can't wait. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Just The News No Noise John Solomon Amanda Head #MedicalFreedom
0:54

JAMA Reported That Ivermectin and Mebendazole Use in Cancer Patients Has Skyrocketed. The NCI Has Been Watching. Now They Need to Act. A report from Rockwell and colleagues in JAMA confirms what patient data has been showing for over a year — use of ivermectin and mebendazole among cancer patients surged through 2025. Mel Gibson's appearance on Joe Rogan accelerated it further. The first clinical report shows 84% positive impact — cancers held stable or improved when the combination was added to traditional care. The National Cancer Institute is tracking this. The next step is a large prospective randomized double-blind placebo-controlled trial. The data is there. The patients can't wait. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Just The News No Noise John Solomon Amanda Head #MedicalFreedom

McCullough Foundation

20,252 views • 2 months ago

Ivermectin and Mebendazole Cost a Fraction of Chemo. Big Pharma Can't Patent Them. That's the Problem. Cancer centers get a cut of every chemotherapy bill. Generic drugs don't generate that margin. Two affordable, widely available compounds showing 84% clinical benefit in a real-world cancer cohort still don't have a single large-scale randomized trial behind them — not because the science isn't there, but because the incentive structure isn't. The National Cancer Institute needs to run the trial. The patients can't keep waiting. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Steve Gruber Daybreak, The Steve Gruber Show Steve Gruber #MedicalFreedom
1:13

Ivermectin and Mebendazole Cost a Fraction of Chemo. Big Pharma Can't Patent Them. That's the Problem. Cancer centers get a cut of every chemotherapy bill. Generic drugs don't generate that margin. Two affordable, widely available compounds showing 84% clinical benefit in a real-world cancer cohort still don't have a single large-scale randomized trial behind them — not because the science isn't there, but because the incentive structure isn't. The National Cancer Institute needs to run the trial. The patients can't keep waiting. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Steve Gruber Daybreak, The Steve Gruber Show Steve Gruber #MedicalFreedom

McCullough Foundation

33,132 views • 4 months ago

What Is a Turbo Cancer? A Cardiologist With 40 Years of Practice Says He's Never Seen Anything Like It. Younger patients. More aggressive at presentation. Progressing faster than anything in the textbooks. A bladder cancer so rapidly growing an entire organ had to be removed. Colon cancer now the leading cancer in men under 45. Turbo cancer isn't a fringe term — it's a clinical observation being documented across practices nationwide, and the pattern is new. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Faith and Freedom, Shemane Nugent Shemane Nugent #MedicalFreedom
1:04

What Is a Turbo Cancer? A Cardiologist With 40 Years of Practice Says He's Never Seen Anything Like It. Younger patients. More aggressive at presentation. Progressing faster than anything in the textbooks. A bladder cancer so rapidly growing an entire organ had to be removed. Colon cancer now the leading cancer in men under 45. Turbo cancer isn't a fringe term — it's a clinical observation being documented across practices nationwide, and the pattern is new. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Faith and Freedom, Shemane Nugent Shemane Nugent #MedicalFreedom

McCullough Foundation

18,463 views • 4 months ago

Nearly One in Two Cancer Patients Saw Their Cancer Go Into Remission or Improve. Let That Sink In. Not stable. Not managed. Remission or improvement — in a real-world cohort of nearly 200 cancer patients on off-label ivermectin and mebendazole. The study is under peer review. The drugs are already on pharmacy shelves. The National Cancer Institute has an obligation to take this to a large-scale controlled trial immediately. Join the Fight: Courtesy of Newsmax NEWSMAX, Katrina Szish KATRINA SZISH, Bob Brooks Bob Brooks #MedicalFreedom
1:16

Nearly One in Two Cancer Patients Saw Their Cancer Go Into Remission or Improve. Let That Sink In. Not stable. Not managed. Remission or improvement — in a real-world cohort of nearly 200 cancer patients on off-label ivermectin and mebendazole. The study is under peer review. The drugs are already on pharmacy shelves. The National Cancer Institute has an obligation to take this to a large-scale controlled trial immediately. Join the Fight: Courtesy of Newsmax NEWSMAX, Katrina Szish KATRINA SZISH, Bob Brooks Bob Brooks #MedicalFreedom

McCullough Foundation

44,547 views • 3 months ago

Cancer Patients Have No Generic Options. Everything Must Be Branded. Offered Through a Cancer Center. After 40 Years in Practice, the Suspicion Is Now Intentional Suppression. Ivermectin and mebendazole — cheap, widely available, showing 84% clinical benefit in cancer patients — are not offered through a single cancer center in the country. Everything in oncology must be branded, patented, and administered through a book-and-bill relationship that profits the center. The biomedical deep state didn't disappear with the new administration. Vaccine reform has been slower than promised. The mRNA platform has been green-lit for RSV and influenza without preclinical safety testing. The machine is still running. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Faith and Freedom, Shemane Nugent Shemane Nugent #MedicalFreedom
1:26

Cancer Patients Have No Generic Options. Everything Must Be Branded. Offered Through a Cancer Center. After 40 Years in Practice, the Suspicion Is Now Intentional Suppression. Ivermectin and mebendazole — cheap, widely available, showing 84% clinical benefit in cancer patients — are not offered through a single cancer center in the country. Everything in oncology must be branded, patented, and administered through a book-and-bill relationship that profits the center. The biomedical deep state didn't disappear with the new administration. Vaccine reform has been slower than promised. The mRNA platform has been green-lit for RSV and influenza without preclinical safety testing. The machine is still running. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Faith and Freedom, Shemane Nugent Shemane Nugent #MedicalFreedom

McCullough Foundation

14,542 views • 1 month ago

Cancer Cells and Parasites Feed the Same Way. That's Why This Drug Combination Works. Both drain energy from the host using similar biological mechanisms. Ivermectin and mebendazole — developed to fight parasites — disrupt that process in cancer cells too. They reduce proliferation, cut off the blood supply tumors try to build, and accelerate the packaging and termination of cancer cells. Over 100 pre-clinical studies confirm it. The human data just confirmed it at scale. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), The Steve Gruber Show Steve Gruber #MedicalFreedom
0:54

Cancer Cells and Parasites Feed the Same Way. That's Why This Drug Combination Works. Both drain energy from the host using similar biological mechanisms. Ivermectin and mebendazole — developed to fight parasites — disrupt that process in cancer cells too. They reduce proliferation, cut off the blood supply tumors try to build, and accelerate the packaging and termination of cancer cells. Over 100 pre-clinical studies confirm it. The human data just confirmed it at scale. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), The Steve Gruber Show Steve Gruber #MedicalFreedom

McCullough Foundation

16,051 views • 4 months ago

Generic Drugs With Decades of Safety Data. Promising Early Results. Still No Large Trials. That Needs to Change Now. Ivermectin. Mebendazole. Repurposed compounds with established safety profiles and mounting evidence of efficacy — in cancer, in infection, in chronic disease. The pipeline for large-scale trials exists. The incentive structure doesn't support it. RFK and the National Cancer Institute have an opportunity to fast-track what Big Pharma won't touch. The data is ready. The patients can't wait. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Just The News No Noise, John Solomon John Solomon, Amanda Head Amanda Head #MedicalFreedom
0:35

Generic Drugs With Decades of Safety Data. Promising Early Results. Still No Large Trials. That Needs to Change Now. Ivermectin. Mebendazole. Repurposed compounds with established safety profiles and mounting evidence of efficacy — in cancer, in infection, in chronic disease. The pipeline for large-scale trials exists. The incentive structure doesn't support it. RFK and the National Cancer Institute have an opportunity to fast-track what Big Pharma won't touch. The data is ready. The patients can't wait. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Just The News No Noise, John Solomon John Solomon, Amanda Head Amanda Head #MedicalFreedom

McCullough Foundation

11,283 views • 4 months ago

Senate Confirmation Hearings on Robert F. Kennedy, Jr, for Secretary of Health and Human Services will be Like David versus Goliath Corrupt BIG FOOD, BIG PHARMA, former U.S. FDA Commissioner Pfizer Inc. Gottlieb all lobbying to senators to sink the nomination. Dr. McCullough on Live at Studio 6B on Real America's Voice. Real America's Voice (RAV) Live From Studio 6B Robert F. Kennedy Jr Donald J. Trump
1:30

Senate Confirmation Hearings on Robert F. Kennedy, Jr, for Secretary of Health and Human Services will be Like David versus Goliath Corrupt BIG FOOD, BIG PHARMA, former U.S. FDA Commissioner Pfizer Inc. Gottlieb all lobbying to senators to sink the nomination. Dr. McCullough on Live at Studio 6B on Real America's Voice. Real America's Voice (RAV) Live From Studio 6B Robert F. Kennedy Jr Donald J. Trump

Peter A. McCullough, MD, MPH®

104,773 views • 1 year ago

Patterns in Cancer That Have Never Been Seen Before. Time Magazine Put It on the Cover. Nobody Connected the Dots. Multiple cancer types in a single patient. Colon cancer rising in men under 45. Cancers appearing at younger ages, progressing faster, presenting more severely. Time Magazine described the phenomenon without naming a cause. The clinical data pointing to a post-pandemic origin has been in the peer-reviewed literature for two years. The mainstream press still won't say it. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Faith and Freedom, Shemane Nugent Shemane Nugent #MedicalFreedom
1:33

Patterns in Cancer That Have Never Been Seen Before. Time Magazine Put It on the Cover. Nobody Connected the Dots. Multiple cancer types in a single patient. Colon cancer rising in men under 45. Cancers appearing at younger ages, progressing faster, presenting more severely. Time Magazine described the phenomenon without naming a cause. The clinical data pointing to a post-pandemic origin has been in the peer-reviewed literature for two years. The mainstream press still won't say it. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Faith and Freedom, Shemane Nugent Shemane Nugent #MedicalFreedom

McCullough Foundation

27,141 views • 4 months ago

To Stay More Free of Colds and Flu Most Are Skipping the Flu Shot Yes, influenza vaccination backfires and increases the risk of common cold viruses and influenza. With <50% theoretical efficacy and serious adverse events like Guillain-Barré syndrome (GBS), many healthcare professionals have changed their advice to avoiding influenza vaccination. Live From Studio 6B Real America's Voice (RAV) McCullough Foundation
0:43

To Stay More Free of Colds and Flu Most Are Skipping the Flu Shot Yes, influenza vaccination backfires and increases the risk of common cold viruses and influenza. With <50% theoretical efficacy and serious adverse events like Guillain-Barré syndrome (GBS), many healthcare professionals have changed their advice to avoiding influenza vaccination. Live From Studio 6B Real America's Voice (RAV) McCullough Foundation

Peter A. McCullough, MD, MPH®

169,796 views • 11 months ago